275 related articles for article (PubMed ID: 26119311)
1. [Bone and Nutrition. The vitamin D functions in osteoblasts and osteocytes].
Sawatsubashi S
Clin Calcium; 2015 Jul; 25(7):991-7. PubMed ID: 26119311
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands.
Jurutka PW; Bartik L; Whitfield GK; Mathern DR; Barthel TK; Gurevich M; Hsieh JC; Kaczmarska M; Haussler CA; Haussler MR
J Bone Miner Res; 2007 Dec; 22 Suppl 2():V2-10. PubMed ID: 18290715
[TBL] [Abstract][Full Text] [Related]
3. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
4. The direct role of vitamin D on bone homeostasis.
St-Arnaud R
Arch Biochem Biophys; 2008 May; 473(2):225-30. PubMed ID: 18424254
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts.
Masuyama R; Stockmans I; Torrekens S; Van Looveren R; Maes C; Carmeliet P; Bouillon R; Carmeliet G
J Clin Invest; 2006 Dec; 116(12):3150-9. PubMed ID: 17099775
[TBL] [Abstract][Full Text] [Related]
6. VDR dependent and independent effects of 1,25-dihydroxyvitamin D3 on nitric oxide production by osteoblasts.
Willems HM; van den Heuvel EG; Carmeliet G; Schaafsma A; Klein-Nulend J; Bakker AD
Steroids; 2012 Jan; 77(1-2):126-31. PubMed ID: 22093484
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D.
Dusso AS; Brown AJ; Slatopolsky E
Am J Physiol Renal Physiol; 2005 Jul; 289(1):F8-28. PubMed ID: 15951480
[TBL] [Abstract][Full Text] [Related]
8. 1alpha,25-dihydroxyvitamin D3 inducible transcription factor and its role in the vitamin D action.
Nezbedova P; Brtko J
Endocr Regul; 2004 Mar; 38(1):29-38. PubMed ID: 15147236
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D Activity and Metabolism in Bone.
Anderson PH
Curr Osteoporos Rep; 2017 Oct; 15(5):443-449. PubMed ID: 28808890
[TBL] [Abstract][Full Text] [Related]
10. [VDR knockout mice and bone mineralization disorders].
Takeyama K; Yamamoto Y; Kato S
Clin Calcium; 2007 Oct; 17(10):1560-6. PubMed ID: 17906409
[TBL] [Abstract][Full Text] [Related]
11. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
Harant H; Spinner D; Reddy GS; Lindley IJ
J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
[TBL] [Abstract][Full Text] [Related]
12. Autocrine/paracrine action of vitamin D on FGF23 expression in cultured rat osteoblasts.
Tang WJ; Wang LF; Xu XY; Zhou Y; Jin WF; Wang HF; Gao J
Calcif Tissue Int; 2010 May; 86(5):404-10. PubMed ID: 20354682
[TBL] [Abstract][Full Text] [Related]
13. VDR in Osteoblast-Lineage Cells Primarily Mediates Vitamin D Treatment-Induced Increase in Bone Mass by Suppressing Bone Resorption.
Nakamichi Y; Udagawa N; Horibe K; Mizoguchi T; Yamamoto Y; Nakamura T; Hosoya A; Kato S; Suda T; Takahashi N
J Bone Miner Res; 2017 Jun; 32(6):1297-1308. PubMed ID: 28177161
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice.
Takeda S; Yoshizawa T; Nagai Y; Yamato H; Fukumoto S; Sekine K; Kato S; Matsumoto T; Fujita T
Endocrinology; 1999 Feb; 140(2):1005-8. PubMed ID: 9927335
[TBL] [Abstract][Full Text] [Related]
15. 1,25-Dihydroxyvitamin D3 regulates the expression of low-density lipoprotein receptor-related protein 5 via deoxyribonucleic acid sequence elements located downstream of the start site of transcription.
Fretz JA; Zella LA; Kim S; Shevde NK; Pike JW
Mol Endocrinol; 2006 Sep; 20(9):2215-30. PubMed ID: 16613987
[TBL] [Abstract][Full Text] [Related]
16. Plasma membrane Pdia3 and VDR interact to elicit rapid responses to 1α,25(OH)(2)D(3).
Chen J; Doroudi M; Cheung J; Grozier AL; Schwartz Z; Boyan BD
Cell Signal; 2013 Dec; 25(12):2362-73. PubMed ID: 23896121
[TBL] [Abstract][Full Text] [Related]
17. Novel targets of vitamin D activity in bone: action of the vitamin D receptor in osteoblasts, osteocytes and osteoclasts.
Ryan JW; Reinke D; Kogawa M; Turner AG; Atkins GJ; Anderson PH; Morris HA
Curr Drug Targets; 2013 Dec; 14(14):1683-8. PubMed ID: 24010964
[TBL] [Abstract][Full Text] [Related]
18. Non-classical mechanisms of transcriptional regulation by the vitamin D receptor: insights into calcium homeostasis, immune system regulation and cancer chemoprevention.
Dimitrov V; Salehi-Tabar R; An BS; White JH
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():74-80. PubMed ID: 23911725
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D receptor overexpression in osteoblasts and osteocytes prevents bone loss during vitamin D-deficiency.
Lam NN; Triliana R; Sawyer RK; Atkins GJ; Morris HA; O'Loughlin PD; Anderson PH
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():128-31. PubMed ID: 24434283
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D signaling in osteocytes: effects on bone and mineral homeostasis.
Lieben L; Carmeliet G
Bone; 2013 Jun; 54(2):237-43. PubMed ID: 23072922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]